The Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM. The total incident cases of Small Cell Lung Cancer were 85,540 in 7MM IN 2017. The key players in the Small Cell Lung Cancer Market include AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda and others. For more details visit: https://www.delveinsight.com/report-store/small-cell-lung-cancer-market#infographics